Form 4: Myriad Genetics Executive Mark Verratti Reports Stock Disposals for Tax Obligations

Mark Verratti, Chief Commercial Officer of Myriad Genetics, reports disposing of shares to cover tax obligations related to vesting restricted stock units.

Summary

• On March 22 and 24, 2024, Mark Verratti, the Chief Commercial Officer of Myriad Genetics, disposed of shares of common stock to satisfy tax withholding obligations.
• A total of 1,648 shares were disposed of on March 22, 2024, and 1,661 and 1,584 shares were disposed of on March 24, 2024.
• The disposals were related to the vesting of restricted stock units and performance-based restricted stock units.
• The price per share for these transactions was $22.24.
• Following these transactions, Verratti directly owns 299,791 shares of Myriad Genetics common stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock disposals for tax purposes, which is a neutral event.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. Disposals for tax obligations are common when restricted stock units vest.

Stakeholder Impact

• The transactions have a minimal impact on shareholders as they are related to tax obligations and do not indicate a change in the executive's long-term outlook on the company.

Key Dates